Results 141 to 150 of about 403,304 (294)

Durable and Additive Disease Control at 52 Weeks With Ixekizumab Plus Tirzepatide Versus Ixekizumab Alone in Adults With Psoriatic Arthritis and Obesity or Overweight: Additional Results From a Randomized Clinical Trial

open access: yesArthritis &Rheumatology, EarlyView.
Objective Obesity or overweight occurs in 72% to 82% of individuals with psoriatic arthritis (PsA). Previous data revealed greater disease control with concomitant ixekizumab (IXE) and tirzepatide (TZP) versus IXE alone in adults with active PsA and obesity or overweight with at least one weight‐related comorbidity at the week 36 primary end point. The
Joseph F. Merola   +14 more
wiley   +1 more source

Lactoferrin as a Novel Therapeutic Agent in Dermatology: Current Evidence and Future Perspectives

open access: yesClinical, Cosmetic and Investigational Dermatology
Hui Zhang, Xu He, Peisheng Chen, Shanhe Shen, Qibin Liu, Xinling BiDepartment of Dermatology, The First Affiliated Hospital of Naval Medical University, Shanghai, People’s Republic of China*These authors contributed equally to this ...
Zhang H   +5 more
doaj  

DERMATOLOGY

open access: yesJournal of Occupational and Environmental Medicine, 1970
openaire   +1 more source

The development and validation of a new diagnostic sonographic enthesitis score for psoriatic arthritis: Diagnostic Ultrasound Enthesitis Tool (DUET)

open access: yesArthritis &Rheumatology, Accepted Article.
Objective The Diagnostic Ultrasound Enthesitis Tool (DUET) study aimed to develop and validate a new sonographic scoring system for enthesitis to aid PsA diagnosis. Methods We prospectively enrolled patients with early PsA, psoriasis without arthritis (PsO), and non‐inflammatory musculoskeletal symptoms as controls (CTL) from 17 centers. A standardized
Lihi Eder   +27 more
wiley   +1 more source

Exosomes and Hair Regeneration: A Systematic Review of Clinical Evidence Across Alopecia Types and Exosome Sources

open access: yesClinical, Cosmetic and Investigational Dermatology
Mohammed A Al Ameer,1 Abdulaziz T Alnajim,1 Ali Al Ameer,2 Zainab Alsalman,3 Ghadeer A Al Ameer,4 Sarah T Alnajim,5 Anwar A Alghamdi,1 Raniya Moideen,4 Enas M Al Hadi6 1Department of Dermatology, Aseer Central Hospital, Abha, Saudi Arabia; 2Department of
Al Ameer MA   +8 more
doaj  

Sjögren's Disease Salivary Gland Fibroblast Subsets are Interferon Enriched and Aberrantly Promote Pain

open access: yesArthritis &Rheumatology, Accepted Article.
Objective Fibroblasts are emerging as critical mediators in the pathogenesis of Sjögren's Disease (SjD) onset and progression. This study aimed to define fibroblast subpopulations within salivary glands (SG) and elucidate their functional contributions to SjD pathogenesis. Methods We analyzed 3′ single‐cell RNA sequencing data from minor SG biopsies of
Sara S. McCoy   +84 more
wiley   +1 more source

Relationship of the Specific Inflammatory Cytokines KLK5, IL-8, and IL-22 with Demodex Density and Risk Factors in Rosacea

open access: yesJournal of Inflammation Research
Jingang Xu,1,* Yao Zhang,1,* Chao Ci,2 Xiaohong Lu,2 Xing Hu,3 Jinhong Zhao,1 Yuanyuan Li1 1Department of Medical Parasitology, Wannan Medical College, Wuhu, Anhui, 241002, People’s Republic of China; 2Department of Dermatology, Yijishan ...
Xu J   +6 more
doaj  

Author Correction: Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials. [PDF]

open access: yesNat Med
Porter ML   +22 more
europepmc   +1 more source

Pediatric dermatology /

open access: yes
Clinically focused and practical, this diagnostic reference is ideal for anyone who treats children with skin disorders. Over 800 top-quality full-color illustrations, balanced by clear and succinct text, deliver the right amount of clinical detail to ...
Cohen, Bernardauthor.
core  

Home - About - Disclaimer - Privacy